Lonza | LONN - Cost Of Sales

Stock Price
470.50
Daily Change
-2.80 -0.59%
Monthly
-9.62%
Yearly
-17.22%
Q1 Forecast
468.93

Lonza reported CHF2.28B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.2B 46M Dec/2025
Almirall EUR 191.5M 2.29M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Demant DKK 2.89B 188M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Geberit CHF 229.8M 22.8M Dec/2025
Genmab DKK 81M 23M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GN Store Nord DKK 2.24B 338M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Sika AG CHF 2.77B 49.8M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Solvay EUR 860M 71M Dec/2025
UCB EUR 1.07B 146M Dec/2025